Abstract:Nutrition exerts considerable effects on health, and dietary interventions are commonly used to treat diseases of metabolic aetiology. Although cancer has a substantial metabolic component1, the principles that define whether nutrition may be used to influence outcomes of cancer are unclear2. Nevertheless, it is established that targeting metabolic pathways with pharmacological agents or radiation can sometimes lead to controlled therapeutic outcomes. By contrast, whether specific dietary interventions can influence the metabolic pathways that are targeted in standard cancer therapies is not known. Here we show that dietary restriction of the essential amino acid methionine-the reduction of which has anti-ageing and anti-obesogenic properties-influences cancer outcome, through controlled and reproducible changes to one-carbon metabolism. This pathway metabolizes methionine and is the target of a variety of cancer interventions that involve chemotherapy and radiation. Methionine restriction produced therapeutic responses in two patient-derived xenograft models of chemotherapy-resistant RAS-driven colorectal cancer, and in a mouse model of autochthonous soft-tissue sarcoma driven by a G12D mutation in KRAS and knockout of p53 (KrasG12D/+;Trp53-/-) that is resistant to radiation. Metabolomics revealed that the therapeutic mechanisms operate via tumour-cell-autonomous effects on flux through one-carbon metabolism that affects redox and nucleotide metabolism-and thus interact with the antimetabolite or radiation intervention. In a controlled and tolerated feeding study in humans, methionine restriction resulted in effects on systemic metabolism that were similar to those obtained in mice. These findings provide evidence that a targeted dietary manipulation can specifically affect tumour-cell metabolism to mediate broad aspects of cancer outcome.

Targeting methionine metabolism in cancer: opportunities and challenges

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Nanomedicines Targeting Metabolism in the Tumor Microenvironment

Targeting T Cell Metabolism in the Tumor Microenvironment: an Anti-Cancer Therapeutic Strategy

Methionine Metabolism in Health and Cancer: a Nexus of Diet and Precision Medicine

Technologies for Targeting DNA Methylation Modifications: Basic Mechanism and Potential Application in Cancer.

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment

Methylomics and cancer: the current state of methylation profiling and marker development for clinical care

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

Metabolism of Amino Acids in Cancer

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer.

Therapeutic strategies targeting metabolic characteristics of cancer cells

A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future

Targeting amino acid metabolism for cancer therapy

Targeting Mitochondrial Metabolic Reprogramming As a Potential Approach for Cancer Therapy

Targeting Non-histone Methylation in Gastrointestinal Cancers: From biology to clinic

Targeting the Dynamics of Cancer Metabolism in the Era of Precision Oncology.

Dietary Methionine Influences Therapy in Mouse Cancer Models and Alters Human Metabolism